All PlansCoverageMedium impact
Recall: Metformin ER
UPMC Health Plan·Endocrinology, Internal Medicine, Family Medicine +1 more·Pharmacy
We identified it
Aug 7, 2026
Summary
Viona Pharmaceuticals Inc. has recalled 33 lots of Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg due to impurity levels exceeding FDA standards. This is a product-level pharmaceutical recall that may affect patient medications and requires coordination with pharmacy and clinical teams to identify affected patients and ensure alternative medications are provided.
Action Required
Immediately: Coordinate with pharmacy department and clinical providers to identify patients currently prescribed the recalled Metformin ER 750 mg lots. Obtain the complete list of affected lot numbers from the source URL. Contact affected patients to notify them of the recall and work with providers to transition patients to non-recalled Metformin ER or alternative diabetes medications. Ensure all pharmacy claims and billing records flag any prescriptions from the recalled lots. Communicate recall details to all endocrinology, internal medicine, and family medicine providers in the practice. No billing changes are required, but workflow coordination is essential to ensure patient safety and continuity of care.